● Live Tracking 375+ pre-IPO companies with institutional-grade data — updated daily. 140 in active pipeline.

Beacon Biosignals IPO Status 2026

AI-powered neuroscience platform analyzing brain signals for clinical and pharma applications

IndustryAI / Neuroscience / Healthcare
Stageseries_b
IPO StatusPre-IPO
Total Funding~$132M
HeadquartersBoston, MA
How to Invest in Beacon Biosignals
Pre-IPO
🔔 Get Notified When Beacon Biosignals IPOs

No secondary market access for Beacon Biosignals yet. Get instant alerts when an S-1 is filed or IPO date is announced.

Get IPO Alerts →
📡 IPO Intelligence
$49/mo — Unlimited Reports + Real-Time Updates
⚡Unlimited company analysis reports — all 375+ companies
✓Real-time IPO alerts — know the moment S-1s are filed
✓Verified data updated daily — not chatbot hallucinations
💡 Tracking multiple companies? Full access pays for itself after 3 reports.
$49
per month
Subscribe Now →
Cancel anytime · Secure via Stripe
Institutional Research
$19 — Get the Complete Beacon Biosignals Analysis Brief
✓Executive summary & IPO readiness breakdown
✓Competitive positioning & funding trajectory
✓Bull / bear thesis with pricing projections
✓S-1 timeline estimate & risk assessment
$19
One-time
Secure checkout · Stripe · 24h delivery

Frequently Asked Questions

Has Beacon Biosignals filed for an IPO? +

Beacon Biosignals is currently classified as pre-IPO. No S-1 has been publicly filed. Monitor TechStackIPO for the latest IPO status updates.

How much total funding has Beacon Biosignals raised? +

Beacon Biosignals has raised ~$132M in total venture capital funding.

What sector is Beacon Biosignals in? +

Beacon Biosignals is a AI / Neuroscience / Healthcare company. AI-powered neuroscience platform analyzing brain signals for clinical and pharma applications.

What is Beacon Biosignals's IPO readiness score? +

Beacon Biosignals scores 57/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.